PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery
Clinical trial NCT02804776 · COMPLETED
Trial details
- NCT number
- NCT02804776
- Sponsor
- National Cancer Centre, Singapore
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-27
- Primary completion
- 2018-02-21
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.